MAPK11 Protein is a protein that p38β MAPK participates in cellular stress responses and inflammatory signaling:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure and Domain Architecture
MAPK11 encodes p38β mitogen-activated protein kinase, a member of the p38 MAP kinase family[@cuadrado2010]. Unlike the more widely studied p38α (MAPK14), p38β has distinct expression patterns and physiological functions.
MAPK11 Protein is a protein that p38β MAPK participates in cellular stress responses and inflammatory signaling:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Structure and Domain Architecture
MAPK11 encodes p38β mitogen-activated protein kinase, a member of the p38 MAP kinase family[@cuadrado2010]. Unlike the more widely studied p38α (MAPK14), p38β has distinct expression patterns and physiological functions.
Key structural features include:
Kinase domain: Classic bilobal kinase structure with activation loop containing the dual phosphorylation motif (Thr180/Tyr182)
DGF motif: Asp-Phe-Gly sequence in subdomain VII critical for catalysis
Common docking domain: Surface region for substrate and regulator binding
CD domain: C-terminal common docking site for MAP kinase phosphatases and upstream activators[@kuma2005]
The p38β isoform shares 75% sequence identity with p38α but has distinct tissue distribution, with higher expression in brain regions including the [hippocampus](/brain-regions/hippocampus) and basal ganglia[@horowitz2001].
Normal Function
p38β MAPK participates in cellular stress responses and inflammatory signaling:
Stress response: Activated by cellular stress including oxidative stress, UV radiation, and cytokines
Inflammatory signaling: Upstream of and downstream from inflammatory cytokines including IL-1β and TNF-α
Neuronal function: Regulates synaptic plasticity, learning, and memory formation
Cell cycle control: Controls G1/S transition in some cell types
[Apoptosis](/entities/apoptosis) regulation: Can promote or inhibit cell death depending on context
Transcription factor activation: Phosphorylates ATF2, Elk-1, and CREB[@zarubin2005]
Role in Neurodegeneration
p38β MAPK has complex, sometimes contradictory roles in neurodegeneration:
Alzheimer's Disease
p38β is activated in AD brains and correlates with neurofibrillary pathology
Both protective and detrimental roles have been proposed for different p38 isoforms
p38β may have distinct effects compared to p38α in [tau](/proteins/tau) pathology
Inhibitors targeting specific isoforms are being explored[@swiatkowski2020]
Parkinson's Disease
p38 MAPK activation in dopaminergic [neurons](/entities/neurons) of PD brains
6-OHDA and MPTP models show p38 involvement in toxin-induced death
p38 inhibitors protect dopaminergic neurons in some studies
p38β may have different roles than p38α in PD progression[@karunakaran2008]
ALS
p38 MAPK activated in motor neurons of ALS patients and model mice
Mutant SOD1 triggers p38 signaling cascades
p38 inhibitors show protective effects in cellular and animal models
Activates MNK2 and other downstream effectors in ALS[@dreyer2023]
Tauopathies
p38β phosphorylates tau at multiple sites (Ser202, Thr231, Ser396)
Different p38 isoforms may have distinct tau phosphorylation profiles
Isoform-selective inhibitors may modulate tau pathology
Interaction with [GSK-3β](/entities/gsk3-beta) and [CDK5](/proteins/cdk5) in tau kinase pathways[@li2003]
Therapeutic Targeting
p38 MAPK isoforms are targeted by several drug classes:
MAPK11 Protein (p38β) is Mitogen-activated protein kinase 11. It plays roles in neuronal function and has been implicated in various neurological conditions.
See Also
[Neurodegeneration](/diseases/neurodegeneration)
[Ion Channels](/entities/ion-channels)
[Protein Kinases](/entities/protein-kinases)
External Links
[UniProt](https://www.uniprot.org/)
References
[Cuadrado A, Nebreda AR, Mechanisms and functions of p38 MAPK signalling (2010)](https://pubmed.ncbi.nlm.nih.gov/20626350/)
[Kuma Y, Sabio G, Bain J, et al, Structure and function of the MAP kinase p38beta (2005)](https://pubmed.ncbi.nlm.nih.gov/15494203/)
[Horowitz P, Bush RA, Sieving PA, Shinde N, Wensel TG, Regional and cellular localization of the MAP kinases ERK1 and ERK2 in the rat brain (2001)](https://pubmed.ncbi.nlm.nih.gov/11520175/)
[Zarubin T, Han J, Activation and signaling of the p38 MAP kinase pathway (2005)](https://pubmed.ncbi.nlm.nih.gov/15686620/)
[Swiatkowski P, Murugan M, Eyo UB, et al, p38 MAPK/MK2 signaling is required for amyloid-beta-induced neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32917961/)
[Karunakaran S, Saeed A, Matsuda R, et al, Selective activation of p38 MAPK in dopaminergic neurons in an in vitro model of Parkinson's disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18384658/)
[Dreyer SD, Sarma R, p38 MAPK in ALS: from pathogenesis to therapeutic targeting (2023)](https://pubmed.ncbi.nlm.nih.gov/36347104/)
[Li Y, Liu L, Barger SW, Interleukin-1beta mediates neuronal cell death via activation of p38 MAPK in Alzheimer's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12498953/)
[Yong HY, Koh MS, Teno A, p38 MAPK signaling pathway in neurodegeneration: friend or foe? Arch Pharm Res (2014)](https://pubmed.ncbi.nlm.nih.gov/24844526/)